Cannabics Pharmaceuticals gains new technology patent

Bethesda-based Cannabics Pharmaceuticals Inc.,  a company involved in cannabinoid diagnostics for the personalized treatment of cancer, announced Wednesday the receipt of a Notice of Allowance from The Patent Office of the State of Israel, which intends to grant Cannabics the patent for its method of high throughput screening of cancer cells. The patent encompasses the technology required to produce ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *